Kasprzyk-Hordern Barbara, Jagadeesan Kishore, Sims Natalie, Farkas Kata, Proctor Kathryn, Bagnall John, Robertson Megan, Jones Davey L, Wade Matthew J
Department of Chemistry, University of Bath, Claverton Down, Bath BA2 7AY, United Kingdom.
Department of Chemistry, University of Bath, Claverton Down, Bath BA2 7AY, United Kingdom.
Water Res. 2025 Jan 1;268(Pt A):122527. doi: 10.1016/j.watres.2024.122527. Epub 2024 Oct 9.
This study identifies biochemical markers (BCIs) that can be used as population markers in wastewater-based epidemiology (WBE) and compares their estimates with other established population size estimation (PE) methods, including census data (PE). Several groups of BCIs (64 targets: genetic and chemical markers) were investigated in an intercity study, including 10 cities/towns within England equating to a population of ∼7 million people. Several selection criteria were applied to identify the best BCIs to provide robust estimation of population size at a catchment level: (1) excellent performance with analytical methods; (2) excellent fit of the linear regression model which indicates PE-driven BCI daily loads; (3) low temporal variability in usage; (4) human-linked origin. Only a few tested BCIs showed a strong positive linear correlation between daily BCI loads and PE indicating their low spatiotemporal variability. These are: cimetidine, clarithromycin, metformin, cotinine, bezafibrate, metronidazole and hydroxymetronidazole, diclofenac, and benzophenone 1. However, only high/long term usage pharmaceuticals: cimetidine and metformin as well as cotinine (metabolite of nicotine) performed well when tested in two independent datasets and catchments accounting for both spatial and temporal scales. Strong seasonal usage trends were observed for antihistamines, NSAIDs (anti-inflammatories), antibiotics and UV filters, invalidating them as PE markers. Key conclusions from the study are: (1) Cimetidine is the best performing BCI; (2) Chemical markers outperform genetic markers as PE BCIs; (3) Water utility PE estimates (PE) align well with PE and PE values; (4) Ammonium/orthophosphate as well as viral PE markers suffer from high temporal variability, hence, they are not recommended as PE markers, and, most importantly, (5) PE calibration/validation at the country/region level is advised in order to establish the best PE markers suited for local/national needs and accounting for site/region specific uncertainties.
本研究确定了可作为基于废水的流行病学(WBE)中人群标志物的生化标志物(BCIs),并将其估计值与其他既定的人口规模估计(PE)方法进行比较,包括人口普查数据(PE)。在一项城际研究中调查了几组BCIs(64个目标:基因和化学标志物),该研究涵盖了英格兰境内的10个城镇,总人口约700万。应用了几个选择标准来确定最佳的BCIs,以便在流域层面提供可靠的人口规模估计:(1)在分析方法方面表现出色;(2)线性回归模型拟合良好,表明由人口规模驱动的BCI日负荷;(3)使用中的时间变异性低;(4)与人类相关的来源。只有少数经过测试的BCIs在BCI日负荷与人口规模之间显示出强正线性相关,表明它们的时空变异性低。这些标志物包括:西咪替丁、克拉霉素、二甲双胍、可替宁、苯扎贝特、甲硝唑和羟基甲硝唑、双氯芬酸以及二苯甲酮1。然而,只有高/长期使用的药物:西咪替丁、二甲双胍以及可替宁(尼古丁的代谢物)在两个独立的数据集中和考虑了空间和时间尺度的流域中进行测试时表现良好。观察到抗组胺药、非甾体抗炎药(抗炎药)、抗生素和紫外线过滤剂有强烈的季节性使用趋势,这使得它们不能作为人口规模标志物。该研究的主要结论是:(1)西咪替丁是表现最佳的BCI;(2)作为人口规模标志物的化学标志物优于基因标志物;(3)自来水公司的人口规模估计(PE)与人口普查(PE)和其他PE值吻合良好;(4)铵/正磷酸盐以及病毒人口规模标志物存在高时间变异性,因此,不建议将它们作为人口规模标志物,最重要的是,(5)建议在国家/地区层面进行人口规模校准/验证,以便确定适合当地/国家需求并考虑到地点/地区特定不确定性的最佳人口规模标志物。